KODIAK SCIENCES INC. Operating Lease, Weighted Average Discount Rate, Percent
KODIAK SCIENCES INC. (KOD) had Operating Lease, Weighted Average Discount Rate, Percent of 6.80% as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-31
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.80%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.80%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.80%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.80%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 6.80% 10-K · filed 2026-03-31 |
| 2024-12-31 | 6.80% 10-K · filed 2026-03-31 |
| 2023-12-31 | 6.80% 10-K · filed 2025-03-27 |
| 2022-12-31 | 6.80% 10-K · filed 2024-03-28 |
| 2021-12-31 | 6.70% 10-K · filed 2023-03-28 |
| 2020-12-31 | 6.70% 10-K · filed 2022-03-01 |
| 2019-12-31 | 8.50% 10-K · filed 2021-03-01 |
| 2019-09-30 | 8.50% 10-Q · filed 2019-11-12 |
| 2019-06-30 | 8.50% 10-Q · filed 2019-08-14 |
| 2019-03-31 | 8.50% 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |